First published · Last updated
Epstein-Barr virus gp350 neutralizing epitopes define distinct sites of vulnerability
A journal article published by Elsevier on 2026-10-01 reports that Epstein-Barr virus gp350 neutralizing epitopes define distinct sites of vulnerability. The supplied source fields did not include additional methodological, quantitative, or impact details.
Categories: science-and-space, public-health
Generated scores
Scores are based on the cited reporting and use a 1–10 scale. Read the methodology.
- Confidence
- 6/10
- Geographic reach
- 2/10
- Global importance
- 3/10
- Impact magnitude
- 2/10
- Positivity
- 6/10
- Urgency
- 1/10
Why it matters
The report identifies sites of vulnerability on Epstein-Barr virus gp350.

